Search Results for 'Rbv-Alfa'

Rbv-Alfa published presentations and documents on DocSlides.

C-WORTHY Study Part D: grazoprevir + elbasvir + RBV in genotype 3

C-WORTHY Study Part D: grazoprevir + elbasvir + RBV in genotype 3

by UnicornLove

C-WORTHY/D. GZR + EBR + RBV. GZR + EBR + RBV. N =...

Daclatasvir + Sofosbuvir + RBV in GT3

Daclatasvir + Sofosbuvir + RBV in GT3

by sophia2

. with Advanced Liver Disease. ALLY-3+ Study. Phas...

by debby-jeon

SOF + RBV. Randomisation*. 1 : 1 : 1. Open-label....

SOF + EBR + GZR + RBV

SOF + EBR + GZR + RBV

by test

N = 12. N = 13. W24. W16. SOF + EBR + GZR + RBV. ...

by min-jolicoeur

Randomisation. Open-label. W8. * Liver biopsy or ...

FISSION Design Objective

FISSION Design Objective

by travis

Non . inferiority. of SOF + RBV : SVR. 12. (. 2-...

Pharmacometrics and Biostatistics Interactions at the FDA

Pharmacometrics and Biostatistics Interactions at the FDA

by byrne

Jeffry Florian, Ph.D.. Division of Pharmacometrics...

Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology

Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology

by badra

Duke University School of Medicine. Durham, North ...

How to optimize treatment of G1 patients?

How to optimize treatment of G1 patients?

by KissesForYou

Prof. G. K. K. Lau 2012. Standard of care (SOC) ...

Are (exogenous) interferons

Are (exogenous) interferons

by amey

really necessary?. Peter . Ferenci. Medical Univer...

522432468WPbVZOeORbVcPSUZbVSTZZeWUTbVaTbVSgcbeeWbVaSWRbVObVbbVgTTWRc

522432468WPbVZOeORbVcPSUZbVSTZZeWUTbVaTbVSgcbeeWbVaSWRbVObVbbVgTTWRc

by daisy

B7AB8DW10--62712/0216U28411204- f-25189455DVReWbVT...

M.W. Fried , 1 M. Buti,

M.W. Fried , 1 M. Buti,

by iamamercy

2. G.J. Dore,. 3. P. Ferenci,. 4. . I. Jacobson...

Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care

Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care

by webraph

Sameh W. Boktor, MD, MPH. Medical Epidemiologist. ...

HCV Clinical Management TRAINER(S)

HCV Clinical Management TRAINER(S)

by trish-goza

IAPAC African Regional Capacity-Building Hub. Bas...

Hepatitis C Imtiaz Alam, M.D.

Hepatitis C Imtiaz Alam, M.D.

by olivia-moreira

Medical Director, Austin Hepatitis Center. 1. Hep...

Updates in Treatment of Hepatitis C

Updates in Treatment of Hepatitis C

by myesha-ticknor

Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...

HCV Clinical Management TRAINER(S)

HCV Clinical Management TRAINER(S)

by danika-pritchard

IAPAC African Regional Capacity-Building Hub. Bas...

Updates in Treatment of Hepatitis C

Updates in Treatment of Hepatitis C

by cheryl-pisano

Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...

Prevention strategies for HIV/HCV co infection

Prevention strategies for HIV/HCV co infection

by giovanna-bartolotta

Isabelle Andrieux-Meyer, MD. Médecins Sans Front...

Updated Guidelines for Managing HIV/HCV Co-Infection

Updated Guidelines for Managing HIV/HCV Co-Infection

by karlyn-bohler

John J . Faragon. , . PharmD. , BCPS, AAHIV-P. Re...

Chronic hepatitis C: guidelines for screening and

Chronic hepatitis C: guidelines for screening and

by aaron

treatment. Lisa M. Glass, MD. Clinical Lecturer. ...

Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care

Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care

by lois-ondreau

Sameh W. Boktor, MD, MPH. Medical Epidemiologist....

OBV/PTV/r DSV Open label

OBV/PTV/r DSV Open label

by kittie-lecroy

≥ 18 years. Chronic HCV infection. Genotype 1. ...

OBV/PTV/r DSV RBV OBV/PTV/r

OBV/PTV/r DSV RBV OBV/PTV/r

by ellena-manuel

DSV . placebo. Randomisation*. Partial blind. 1...

by pamella-moone

* Liver biopsy or . Fibroscan. ≤. 12.5 . kPa....

by sherrill-nordquist

SOF + SMV + RBV. SOF + SMV. Randomisation. 2 : 1 ...

by stefany-barnette

Randomisation*. Open-label. >. 18 years. HCV ...

by ellena-manuel

X. J . Hepatology. 2015; 63: 564-72. C-SALVAGE ...

by celsa-spraggs

N = 69. >. 18 years. Failure to SOF/VEL . or ...

SMV 12W + PEG-IFN + RBV 24-48W **

SMV 12W + PEG-IFN + RBV 24-48W **

by alexa-scheidler

SMV 24W + PEG-IFN + RBV 24-48W **. Randomisation ...

by calandra-battersby

+ . Grazoprevir. +/- Ribavirin in . Treatment-N...

by ellena-manuel

Feld JJ. NEJM . 2014;370:1594-1603. SAPPHIRE-I . ...

by kittie-lecroy

Paritaprevir. -. Ritonavir. . and . Dasabuvir. ...

by myesha-ticknor

Hepatol. 2016; 64:19-28. MALACHITE. TVR + PEG-IF...

C-WORTHY Study Part

C-WORTHY Study Part

by karlyn-bohler

D : . grazoprevir. . + . elbasvir. + RBV in ge...

by marina-yarberry

OBV/PTV/r + . DSV . + RBV. OBV/PTV/r + . DSV . + ...

by tawny-fly

Design. C-SCAPE . Study. : . grazoprevir. ± . e...

by pamella-moone

*. 1:1. Open-label. ≥ 18 years. HCV genotype ...

by pasty-toler

Hepatol. 2016; 64:19-28. MALACHITE. TVR + PEG-IF...

Hepatitis C Drug Pipeline

Hepatitis C Drug Pipeline

by cheryl-pisano

HCV WORLD CAB .  FEBRUARY 2014. BANGKOK, THAI...